期刊文献+

二甲双胍的临床应用 被引量:12

The clinical application of metformin
原文传递
导出
摘要 二甲双胍的临床作用包括控制血糖和糖尿病的危险因素,阻断糖耐量减低或空腹血糖受损,调整糖尿病体质,治疗代谢综合征,改善胰岛素抵抗并治疗胰岛素抵抗相关疾病及多囊卵巢综合征等;还可通过抗蛋白质糖化、抗血小板、抗自由基、抗血管内皮慢性炎症等作用防治糖尿病慢性血管并发症。对慢性心力衰竭可能有益,且不良反应较少。二甲双胍临床适应证有所扩大,可安全地用于糖尿病及其并发症的防治。 Mefformin can be used to control blood glucose and risk factors of diabetes mellitus, including preventing impaired glucose toleraree and impaired fast glucose, adjusting diabetic patients' constitution, treating metabolism syndrome, improving insulin resistance and related diseases as well as polycystic ovarian syndrome and so on. It also has the function of anti-pretein glycation, antiplatelet, anti-free radical, intercept the chronic inflammarion action. So it can be used to prevent and cure chronic vascular complication in diabetic patients. Mefformin may be beneficial to chronic heart failure, and have few side effections. Accordingly, metfirmin can be used to prevent and cure diabetes and its complications with safety.
出处 《国际内分泌代谢杂志》 2006年第3期152-154,共3页 International Journal of Endocrinology and Metabolism
关键词 二甲双胍 临床应用 糖尿病 胰岛素抵抗 Mefformin Clinical application Diabetes Insulin resistance
  • 相关文献

参考文献35

  • 1Kouki T,Takasu N, Nakachi A, et al. Low-dose mefformin improves hyperglycaemia related to myotonic dystrophy. Diabet Med, 2005,22: 346-347.
  • 2Kadmon PM, Gruppuso PA. Glycemic control with metformin or insulin therapy in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab, 2004,17.1185-1193.
  • 3Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 2002,346: 393-403.
  • 4Diabetes Prevention Program Research Group. Fffects of withdrawal from metformin on the development of diabetes in the diabetes prevention program. Diabetes Care, 2003,26: 977-980.
  • 5Rodriguez-Moctezutma JR, Robles-Lopez G, Lopez-Carmona JM, et al. Effects of metformin on the body composition in subjects with risk factors for type 2 diabetes. Diabetes Obes Metab,2005,7:189-192.
  • 6Vitale C, Mercuro G, Comoldi A, et al. Metformin improves endothelial function in patients with metabolic syndrome. J Intern Med, 2005,258:250-256.
  • 7Herrmann BL, Saller B, Stratmann M, et al. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome. Horm Metab Res, 2005,37:49-52.
  • 8Kilicdag EB, Bagis T, Zeyneloglu HB, et al. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study. Hum Reprod, 2005,20: 894-899.
  • 9Tankova T. Current indications for metformin therapy, Rom J Intern Med, 2003,41:215-225.
  • 10Komori T, Yoshida F, Nakamura J,et al. Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effects on eating behavior and serum leptin levels. Exp Clin Endocrinol Diabetes,2004,112:422-428.

同被引文献98

引证文献12

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部